The median non-prostate cancer sur- vival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer. Radiat Oncol. 2007;2:17.Blood PA, Pickles T. The median non-prostate cancer survival is more than 10 years for men ...
Figure2shows the K-M median non-prostate cancer survival by age at start of radiation treatment and the median all-cause survival for all men of the same age in the BC population. The median non-prostate cancer survival is greater than 10 years for men aged up to 80 years at start of ...
As of 2024, it was estimated that the median age in Sabah was 27.4 years old, the highest in the ten-year period of survey.
but also different in application.For the same group of data,there is no definite and strict standard for which one should be used.What's more,different data may even lead to diametrically opposite conclusions.Even if we finally choose one,what extent the data can describe the concentrative ...
Time to all-cause death, adjusted for age, showed a moderately large but statistically nonsignificant HR (MS/FS) of 1.871 (95% CI, 0.723-4.844; P = .1966). Safety analyses excluded 1 patient who was withdrawn before surgery. There were significantly more SAEs in the MS recipients (rate ...
theage of 50 years, with first symptoms of AUR secondary tobenign prostatic hyperplasia, that sought medical attentionat the outpatient service of the Hospital General de M茅xico.The exclusion criteria were: more than one episode ofsymptoms of AUR, patients that had been treated for...
Median age was 68 (IQR 64-74), median PSA was 5.9 ng/mL (IQR 4.1-8.2) and 86% harboured intermediate-risk disease and 7% high-risk disease. Thirty-eight patients progressed to radical treatment (17%) at a median of 35 months post-IRE (17-53). Kaplan-Meier failure-free survival ...
Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median. J Urol 2007;177:1745-8.Loeb S, Nadler RB, Roehl KA, Antenor JA, Catalona WJ. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific ...
Methods Between May 1999 and November 2005, 96 men with clinical stage T1-T2 prostate cancer received 125I prostate \\{BT\\} without androgen deprivation or supplemental external radiotherapy. Median age was 53 years (range 45-55). Minimum follow-up was 30 months and median 63 months (range...
Methods Between May 1999 and November 2005, 96 men with clinical stage T1-T2 prostate cancer received 125I prostate \\\{BT\\\} without androgen deprivation or supplemental external radiotherapy. Median age was 53 years (range 45-55). Minimum follow-up was 30 months and median 63 months (ra...